June 2021

Abstract

ASCO Annual Meeting

Flatiron-authored

May 2021

Manuscript

Health Services Research

Flatiron-authored

April 2021

Manuscript

Scientific Reports

Artificial intelligence for prognostic scores in oncology: a benchmarking study

Loureiro, H, Becker, T, Bauer-Mehren, A, Ahmidi, N, Weberpals, J

April 2021

Manuscript

Frontiers in Artificial Intelligence

April 2021

Manuscript

JAMA Oncology

Treatment patterns in patients with metastatic non-small-cell lung cancer in the era of immunotherapy

Stenehjem, D, Lubinga, S, Betts, KA, Tang, W, Jenkins, M, Yuan, Y, Hartman, J, Rao, S, Lam, J, Waterhouse, D

April 2021

Manuscript

Future Oncology

April 2021

Abstract

AACR Annual Meeting

Changes over time in real-world next-generation sequencing test use in patients with advanced non-small cell lung cancer

Swaminathan, A, Stergiopoulos, S, Snider, JW, Fisher, V, Castellanos, EH, Snow, T, Cho-Phan, C, Comment, L, Cunningham, R, McCusker, M

April 2021

Abstract

AACR Annual Meeting

Flatiron-authored

Evaluating oncology trial eligibility criteria using real-world data and AI

Liu, R, Rizzo, S, Whipple, S, Pal, N, Pineda, AL, Lu, MW, Arnieri, B, Lu, Y, Capra, WB, Copping, R, Zou, J

April 2021

Manuscript

Nature

Adherence to NCCN ALK testing guidelines for patients with advanced non‐small cell lung cancer in US community medical centers

Bernicker, E, Xiao, Y, Abraham, A, Yang, B, Croix, D, Redpath, S, Engstrom-Melnyk, J, Shah, RA, Madala, J, Allen, TC

April 2021

Manuscript

The Oncologist

Characterization of a real-world response variable and comparison with RECIST-based response rates from clinical trials in advanced NSCLC

Ma, X, Bellomo, L, Magee, K, Bennette, CS, Tymejczyk, O, Samant, MK, Tucker, MG, Nussbaum, NC, Bowser, BE, Kraut, JS, Bourla, AB

March 2021

Manuscript

Advances in Therapy

Flatiron-authored

February 2021

Manuscript

European Journal of Haematology

February 2021

Manuscript

Advances in Therapy

February 2021

Manuscript

NPJ Digital Medicine

Real-world characterization of advanced non-small cell lung cancer in never smokers by actionable mutation status

Kerrigan, KC, Wang, X, Haaland, B, Adamson, BJS, Patel, SB, Puri, S, Akerley, WL

January 2021

Manuscript

Clinical Lung Cancer

Flatiron-authored

January 2021

Manuscript

JCO Clinical Cancer Informatics

January 2021

Manuscript

BMC Cancer

December 2020

Abstract

HTAi

Flatiron-authored

December 2020

Manuscript

Current Medical Research and Opinion

October 2020

Manuscript

Journal of Medical Economics

Flatiron-authored

October 2020

Manuscript

OncoImmunology

STK11 (LKB1) mutations in metastatic NSCLC: prognostic value in the real world

Shire NJ, Klein, AB, Golozar, A, Collins, JM, Fraeman, KH, Nordstrom, BL, McEwen, R, Hembrough, T, Rizvi, NA

September 2020

Manuscript

PLoS One

Retrospective analysis of real-world data to determine clinical outcomes of patients with advanced non-small cell lung cancer following cell-free circulating tumor DNA genomic profiling

Madison, RW, Schrock, AB, Castellanos, EH, Gregg, JP, Snider, J, Ali, SM, Miller, VA, Singal, G, Alexander, BM, Venstrom, JM, Chung, JH

August 2020

Manuscript

Lung Cancer

Flatiron-authored

July 2020

Manuscript

The Oncologist

The adoption of immune checkpoint inhibitors and patterns of care at the end of life

Riaz, F, Gan, G, Li, F, Davidoff, AJ, Adelson, KB, Presley, CJ, Adamson, BJS, Shaw, P, Parikh, RB, Mamtani, R, Gross, CP

July 2020

Manuscript

JCO Oncology Practice

Flatiron-authored

July 2020

Manuscript

The Oncologist

June 2020

Manuscript

JAMA Open

Flatiron-authored

Evaluating the impact of oncology care model reporting requirements on biomarker testing and treatment

Castellanos, EH, Orlando, A, Ma, X, Parikh, RB, O'Connell, G, Meropol, NJ, Hamrick, HJ, Adamson, BJS

June 2020

Manuscript

Journal of Oncology Practice

Flatiron-authored

May 2020

Abstract

AACR Annual Meeting

May 2020

Abstract

AACR Annual Meeting

May 2020

Abstract

ASCO Annual Meeting

Flatiron-authored

A multi-stakeholder platform to prospectively link longitudinal real-world clinico-genomic, imaging, and outcomes data for patients with metastatic lung cancer

Lu, MW, Walia, G, Schulze, K, Doral, MY, Maund, SL, Gaffey, S, Cabili, MN, Bourla, AB, Green, RJ, Santos, EC, Herbst, RS, Chiang, AC, Schwartzberg, L

May 2020

Abstract

ASCO Annual Meeting

Flatiron-authored

The adoption of immune checkpoint inhibitors and patterns of care at the end of life

Riaz, F, Gan, G, Li, F, Davidoff, AJ, Adelson, KB, Presley, CJ, Adamson, BJS, Shaw, P, Parikh, RB, Mamtani, R, Gross, CP

May 2020

Abstract

ASCO Annual Meeting

Flatiron-authored

Real-world outcomes for advanced non-small cell lung cancer patients with EGFR exon 19 deletions stratified by deletion size

Ou, SI, Madison, RW, Snow, T, Snider, J, McCusker, M, Singal, G, Alexander, BM, Venstrom, JM, Castellanos, EH, Schrock, AB

May 2020

Abstract

ASCO Annual Meeting

Flatiron-authored

May 2020

Abstract

ASCO Annual Meeting

May 2020

Abstract

ASCO Annual Meeting

Real-world ALK testing compliance to NCCN guideline and factors of underutilization

Bernicker, E, Xiao, Y, Abraham, A, Engstrom-Melnyk, J, Croix, D, Yang, B, Shah, RA, Madala, J, Allen, T

May 2020

Abstract

ASCO Annual Meeting

Real-world outcomes after second-line treatment in non-small cell lung cancer patients treated with immunotherapy

Marmarelis, ME, Hwang, W-T, Yang, Y-X, Ciunci, C, Singh, A, Aggarwal, C, Cohen, RB, Langer, CJ, Mamtani, R, Bauml, JM

May 2020

Abstract

ASCO Annual Meeting

Prevalence of ALK mutation in advanced NSCLC patients in the United States

Allen, T, Xiao, Y, Abraham, A, Redpath, S, Engstrom-Melnyk, J, Croix, D, Yang, B, Shah, RA, Madala, J, Bernicker, E

May 2020

Abstract

ASCO Annual Meeting

May 2020

Abstract

ASCO Annual Meeting

May 2020

Abstract

ASCO Annual Meeting

Indirect comparison of TAK-788 vs real-world data outcomes in refractory non-small cell lung cancer with EGFR exon 20 insertions

Horn, L, Lin, HM, Padda, SK, Aggarwal, C, McCoach, CE, Zhu, Y, Yin, Y, Li, S, Feng, Z, Neal, JW

May 2020

Abstract

ASCO Annual Meeting

Uptake of first-line immune checkpoint inhibitors among medically frail patients with advanced solid malignancies

Parikh, RB, Cohen, RB, Min, EJ, Wileyto, EP, Riaz, F, Gross, CP, Long, Q, Mamtani, R

May 2020

Abstract

ASCO Annual Meeting

May 2020

Abstract

ASCO Annual Meeting

Overall survival in Non-small cell lung cancer patients with comorbidities treated with frontline chemotherapy or immunotherapy: a real-world data collaboration

Rivera, DR, Lasiter, L, Christian, JB, Enewold, L, Espirito, JL, Hansen, E, Henk, HJ, Kushi, L, Lane, D, Natanzon, Y, Benito, RP, Rasmussen, E, Robert, NJ, Stewart, M, Sweetnam, C, Tymejczyk, O, Valice, E, Wagner, J, Zander, A, Allen, J

May 2020

Abstract

ASCO Annual Meeting

Flatiron-authored

April 2020

Manuscript

ESMO Open

April 2020

Manuscript

Clinical Lung Cancer

Flatiron-authored

April 2020

Manuscript

Lung Cancer

Prognostic significance of cancer patient reported outcomes in cancer

Kerrigan, KC, Patel, SB, Halland, B, Ose, D, Chalmers, AW, Haydell, T, Meropol, NJ, Akerley, WL

January 2020

Manuscript

Journal of Oncology Practice

Flatiron-authored

Association of baseline systemic corticosteroid use with time to next treatment in patients with advanced melanoma, non-small cell lung cancer or urothelial cancer receiving cancer immunotherapy in US clinical practice

Drakaki, A, Dhillon, PK, Wakelee, H, Chui, S, Shim, J, Kent, M, Degaonkar, V, Hoang, T, McNally, V, Luhn, P, Gutzmer, R

December 2019

Abstract

ESMO Immuno-Oncology Congress

Brain metastases, treatment patterns, and outcomes in ROS1-positive NSCLC patients from US oncology community centers

Krebs M,G, Perez, L, Surinach, A, Doebele, RC, Martina, R, Martinec, M, Riehl, T, Meropol, NJ, Wong, WB, Crane, G

November 2019

Abstract

ESMO Asia

Flatiron-authored

Cancer immunotherapy use and effectiveness in real-world patients living with HIV

Adamson, BJS, Cohen, AB, Cheever, MA, Hooley, IJ, Williams, ER, Tymejczyk, O, Peeples, M, Hernandez, M, Meropol, NJ, Uldrick, TS

October 2019

Abstract

International Conference on Malignancies in HIV/AIDS

Flatiron-authored

October 2019

Abstract

Asian Conference on Pharmacoepidemiology

Brain metastases, treatment patterns, and outcomes in ROS1-positive NSCLC patients from US oncology community centers

Krebs, MG, Perez, L, Surinach, A, Doebele, RC, Martina, R, Martinec, M, Riehl, T, Meropol, NJ, Wong, WB, Crane, G

October 2019

Abstract

ESMO Annual Congress

Flatiron-authored

Biomarker status as a mediator of age-related overall survival (OS) in advanced non-small cell lung cancer (aNSCLC)

Cohen, AB, Neri, B, Adamson, BJS, Scanlon, CM, Gross, CP, Meropol, NJ, Miksad, RA

October 2019

Abstract

ESMO Annual Congress

Flatiron-authored

September 2019

Abstract

ESMO Annual Congress

September 2019

Abstract

ESMO Annual Congress

Flatiron-authored

September 2019

Abstract

AACR Special Meeting

Cost effectiveness of PD-L1-based test-and-treat strategy with pembrolizumab as the first-line treatment for metastatic NSCLC in Hong Kong

Loong HH, Wong CKH, Leung LKS, Dhankhar P, Insinga RP, Chandwani S, Hsu DC, Lee MYK, Huang M, Pellissier J, Rai A, Achra M, Tan SC

September 2019

Manuscript

Pharmacoeconomics Open

September 2019

Manuscript

Journal of Oncology Practice

LKB1 mutations in metastatic non-small cell lung cancer (mNSCLC): Prognostic value in the real world

Golozar, A, Collins, J, Fraeman, K, Nordstrom, BL, McEwen, R, Shire, N, Higgs, B

September 2019

Abstract

World Conference on Lung Cancer

Real-world treatment patterns and survival in non-small cell lung cancer patients with EGFR exon 20 insertion mutations

Dersarkissian, M, Bhak, R, Lin, HM, Li, S, Cheng, M, Lax, A, Huang, H, Duh, MS, Ou, S-H

September 2019

Abstract

World Conference on Lung Cancer

September 2019

Abstract

World Conference on Lung Cancer

September 2019

Abstract

World Conference on Lung Cancer

September 2019

Abstract

World Conference on Lung Cancer

September 2019

Abstract

World Conference on Lung Cancer

September 2019

Abstract

World Conference on Lung Cancer

September 2019

Abstract

World Conference on Lung Cancer

September 2019

Abstract

World Conference on Lung Cancer

BRAF mutations are associated with increased benefit from PD-1/PD-L1 blockade compared with other oncogenic drivers in non-small cell lung cancer

Heymach, JV, Shames, DS, Albacker, LA, Frampton, GM, Alexander, BM, Miller, VA, Glisson, BS, Gibbons, DL, Papadimitrakopoulou, V, Tsao, AS, Lee, J, Swisher, S, Roth, JA, Simon, GS, Rinsurongkawong, W, Barreto, D, Zhang, J, Wu, C-J, Goldberg, ME, Le, X, Elamin, Y, Hu, S, Shen, V, Bara, I, Schulze, K, Montesion, M, Skoulidis, F, Negrão, M

September 2019

Abstract

World Conference on Lung Cancer

Real-world outcomes of advanced NSCLC patients with common and uncommon/complex EGFR mutation profiles

Riely, GJ, Lovly, CM, Messina, CGM, Bienert, S, Alexander, K, Pao, W, Magee, K, Baxi, SS, Doebele, RC

September 2019

Abstract

World Conference on Lung Cancer

Flatiron-authored

September 2019

Abstract

World Conference on Lung Cancer

Flatiron-authored

Real-world characterization of advanced non-small cell lung cancer in never smokers

Kerrigan, KC, Halland, B, Adamson, BJS, Patel, SB, Akerley, WL

September 2019

Abstract

World Conference on Lung Cancer

Flatiron-authored

Retrospective analysis of real-world clinico-genomic data for clinical impact of genomic profiling of CTDNA in NSCLC

Madison, R, Schrock, AB, Gregg, JP, Carson, KR, Castellanos, EH, Singal, G, Miller, VA, Ali, SM, Alexander, BM, Chung, JH

September 2019

Abstract

World Conference on Lung Cancer

Flatiron-authored

Comparative efficacy analysis between entrectinib trial and crizotinib real-world ROS1 fusion-positive (ROS1+) NSCLC patients

Doebele, RC, Perez, L, Trinh, H, Martinec, M, Martina, R, Riehl, T, Krebs, MG, Meropol, NJ, Wong, WB, Crane, G

September 2019

Abstract

World Conference on Lung Cancer

Flatiron-authored

August 2019

Abstract

International Conference on Pharmacoepidemiology & Therapeutic Risk Management (ICPE)

August 2019

Abstract

International Conference on Pharmacoepidemiology & Therapeutic Risk Management (ICPE)

August 2019

Abstract

International Conference on Pharmacoepidemiology & Therapeutic Risk Management (ICPE)

Flatiron-authored

Characterizing the feasibility and performance of real-world tumor progression end points and their association with overall survival in a large advanced non–small-cell lung cancer data set

Griffith SD, Miksad RA, Calkins G, You P, Lipitz NG, Bourla AB, Williams E, George DJ, Schrag D, Khozin S, Capra WB, Taylor MD, Abernethy AP

August 2019

Manuscript

JCO Clinical Cancer Informatics

Flatiron-authored

Real‐world progression, treatment, and survival outcomes during rapid adoption of immunotherapy for advanced non–small cell lung cancer

Khozin S, Miksad RA, Adami J, Boyd M, Brown NR, Gossai A, Kaganman I, Kuk D, Rockland JM, Pazdur R, Torres AZ, Zhi J, Abernethy AP

August 2019

Manuscript

Cancer

Flatiron-authored

July 2019

Manuscript

Clinical Pharmacology and Therapeutics

An exploratory analysis of real-world end points for assessing outcomes among immunotherapy-treated patients with advanced non-small-cell lung cancer

Stewart M, Norden AD, Dreyer N, Henk HJ, Abernethy AP, Chrischilles E, Kushi L, Mansfield AS, Khozin S, Sharon E, Arunajadai S, Carnahan R, Christian JB, Miksad RA, Sakoda LC, Torres AZ, Valice E, Allen J

July 2019

Manuscript

JCO Clinical Cancer Informatics

Flatiron-authored

June 2019

Manuscript

JCO Clinical Cancer Informatics

Flatiron-authored

June 2019

Manuscript

Immunotherapy

Affordable Care Act Medicaid expansion impact on racial disparities in time to cancer treatment

Adamson B, Cohen AB, Estevez M, Magee K, Williams E, Gross CP, Meropol NJ, Davidoff AJ

June 2019

Abstract

ASCO Annual Meeting

Flatiron-authored

Organ dysfunction and clinical outcomes in patients treated with immune checkpoint inhibitors

Liu Q, Sharon E, Zineh I, Xie D, Baxi SS, Liu C, Zhi J, Torres AZ, Gossai A, Sridhara R, Booth B, Blumenthal GM, Huang S-M, Khozin S

June 2019

Abstract

ASCO Annual Meeting

Flatiron-authored

Tumor mutational burden and PD-L1 expression as predictors of response to immunotherapy in NSCLC

Castellanos E, Snider J, Ali SM, Backenroth D, Albacker LA, Murugesan K, Li G, Frampton GM, Alexander BM, Carson KR

June 2019

Abstract

ASCO Annual Meeting

Flatiron-authored

June 2019

Abstract

ASCO Annual Meeting

Flatiron-authored

June 2019

Abstract

ASCO Annual Meeting

Flatiron-authored

Genomic characterization of lung tumors and metastatic sites in advanced NSCLC

Willard MD, Smyth EN, Tiu RV, Beyrer J, Zhu YE, Bowman L, Sheffield KM, Han Y, Brastianos P

June 2019

Abstract

ASCO Annual Meeting

June 2019

Abstract

ASCO Annual Meeting

Real-world clinical burden of aggressive disease in advanced/metastatic non small cell lung cancer

Batus M, Stefaniak VJ, Molife C, Clarke JM, Winfree KB, Mitchell L, Cui ZL, Bonom PD

June 2019

Abstract

ASCO Annual Meeting

June 2019

Abstract

ASCO Annual Meeting

June 2019

Abstract

ASCO Annual Meeting

June 2019

Abstract

ASCO Annual Meeting

June 2019

Abstract

ASCO Annual Meeting

June 2019

Abstract

ASCO Annual Meeting

Flatiron-authored

June 2019

Abstract

ASCO Annual Meeting

Flatiron-authored

June 2019

Abstract

ASCO Annual Meeting

Flatiron-authored

June 2019

Abstract

ASCO Annual Meeting

June 2019

Abstract

ASCO Annual Meeting

Clinical characteristics, treatment patterns, and overall survival in advanced NSCLC patients with and without brain metastases

Smyth EN, Tiu RV, Willard MD, Beyrer J, Zhu YE, Bowman L, Sheffield KM, Han Y, Brastianos P

June 2019

Abstract

ASCO Annual Meeting

June 2019

Abstract

ASCO Annual Meeting

Comparative efficacy analysis between entrectinib trial and crizotinib real-world ROS1 fusion-positive (ROS1+) NSCLC patients

Doebele, RC, Perez, L, Trinh, H, Martinec, M, Martina, R, Riehl, T, Krebs, MG, Meropol, NJ, Wong, WB, Crane, G

May 2019

Abstract

ASCO Annual Meeting

Flatiron-authored

May 2019

Manuscript

Advances in Therapy

Flatiron-authored

May 2019

Manuscript

JNCCN

Flatiron-authored

May 2019

Abstract

ISPOR Annual Meeting

May 2019

Abstract

ISPOR Annual Meeting

Machine Learning Model for Cancer Biomarker Identification in Electronic Health Records

Ambwani G, Cohen A, Estévez M, Singh N, Adamson B, Nussbaum N, Birnbaum B

May 2019

Abstract

ISPOR Annual Meeting

Flatiron-authored

April 2019

Manuscript

Clinical Lung Cancer

April 2019

Abstract

European Lung Cancer Conference

Treatment characteristics of patients with locally advanced or metastatic non-small cell lung cancer receiving atezolizumab monotherapy in US clinical practice

Frueh M, Rahma OE, Pachynski RK, Mazieres J, Goldschmidt, Jr J, Ton TGN, Mhatre SK, Chuo C-Y, Martinalbo J, Davies J, Juergens R.

April 2019

Abstract

European Lung Cancer Conference

Association of Patient Characteristics and Tumor Genomics With Clinical Outcomes Among Patients With Non–Small Cell Lung Cancer Using a Clinicogenomic Database

Singal G, Miller PG, Agarwala V, Li G, Kaushik G, Backenroth D, Gossai A, Frampton GM, Torres AZ, Lehnert E, Bourque D, O’Connell C, Bowser B, Caron T, Baydur E, Seidl-Rathkopf K, Ivanov I, Alpha-Cobb G, Guria A, He J, Frank S, Nunnally A, Bailey M, Jaskiw A, Feuchtbaum D, Nussbaum N, Abernethy AP, Miller VA.

April 2019

Manuscript

JAMA

Flatiron-authored

April 2019

Abstract

AACR Annual Meeting

An evaluation of the impact of missing deaths on overall survival analyses of advanced non–small cell lung cancer patients conducted in an electronic health records database

Carrigan, G, Whipple, S, Taylor, MD, Torres, AZ, Gossai, A, Arnieri, B, Tucker, M, Hofmeister, PP, Lambert, P, Griffith, SD, Capra, WB

March 2019

Manuscript

Pharmacoepidemiology & Drug Safety

Flatiron-authored

February 2019

Manuscript

Future Oncology

Disparities in broad-based genomic sequencing for patients with advanced non-small cell lung cancer

Riaz, F, Presley, CJ, Chiang, AC, Longtine, JA, Soulos, PR, Adelson, KB, Herbst, RS, Nussbaum, NC, Sorg, RA, Abernethy, AP, Agarwala, V, Gross, CP

February 2019

Manuscript

Journal of Geriatric Oncology

Flatiron-authored

January 2019

Manuscript

PLoS One

Real-World Outcomes of Patients with Metastatic Non-Small Cell Lung Cancer Treated with Programmed Cell Death Protein 1 Inhibitors in the Year Following U.S. Regulatory Approval

Khozin S, Carson KR, Zhi J, Tucker M, Lee SE, Light DE, Curtis MD, Bralic M, Kaganman I, Gossai A, Hofmeister PP, Torres AZ, Miksad RA, Blumenthal GM, Pazdur R, Abernethy AP

December 2018

Manuscript

The Oncologist

Flatiron-authored

December 2018

Abstract

ESMO Immuno-Oncology Congress

December 2018

Manuscript

Current Medical Research and Opinion

Flatiron-authored

December 2018

Abstract

Machine Learning for Health (ML4H) Workshop

Flatiron-authored

November 2018

Manuscript

Current Medical Research and Opinion

October 2018

Abstract

ESMO Annual Congress

October 2018

Abstract

ESMO Annual Congress

ALK Testing Trends and Patterns Among Community Practices in the United States

Illei P, Wong W, Wu N, Chu L, Gupta R, Schulze K, Gubens M

October 2018

Manuscript

JCO Precision Oncology

Sequencing of Ramucirumab+Docetaxel Postimmune Checkpoint Inhibitors in Advanced Non-Small Cell Lung Cancer

Clarke JM, Stefaniak VJ, Batus M, Winfree KB, Molife C, Cui Z, Han Y, Tawney MK, Bonomi PD

September 2018

Abstract

World Conference on Lung Cancer

Prognosis of Non-Driver, Never Smoker Metastatic Non-Small Lung Cancer (NSCLC)

Chalmers AW, Haaland B, Patel SB, Moynahan K, Cannon L, Akerley W

September 2018

Abstract

World Conference on Lung Cancer

Ramucirumab+Docetaxel Usage Following Rapid Disease Progression in Real World Advanced Non-Small Cell Lung Cancer Patients

Batus M, Molife C, Clarke JM, Stefaniak VJ, Winfree KB, Cui Z, Han Y, Tawney MK, Bonomi PD

September 2018

Abstract

World Conference on Lung Cancer

Treatment Patterns and Overall Survival Following Biomarker Testing in Real-World Advanced NSCLC Patients

Barlesi F, Paz-Ares L, Page D, Shewade A, Lambert P, Mughal T, Gay L, Khorshid M, Arnieri B, Capra W, Foser S, Mascaux C, Bubendorf L, Wang L

September 2018

Abstract

World Conference on Lung Cancer

Real World Biomarker Testing and Treatment Patterns in Patients with Advanced NSCLC Receiving EGFR TKIs

Chiang A, Fernandes A, Pavilack M, Wu J, Laliberté F, Duh MS, Chehab N, Subramanian J

September 2018

Abstract

World Conference on Lung Cancer

September 2018

Manuscript

OncoImmunology

Flatiron-authored

August 2018

Abstract

ACM International Conference on Bioinformatics, Computational Biology, and Health Informatics

The Impact of Missing Deaths on Survival Analyses Conducted in an Oncology EHR Database

Carrigan G, Whipple S, Taylor M, Torres AZ, Gossai A, Arnieri B, Tucker M, Hofmeister PP, Lambert P, Griffith S, Capra W

August 2018

Abstract

International Conference on Pharmacoepidemiology & Therapeutic Risk Management (ICPE)

Flatiron-authored

August 2018

Abstract

International Conference on Pharmacoepidemiology & Therapeutic Risk Management (ICPE)

Flatiron-authored

Association of Broad-Based Genomic Sequencing With Survival Among Patients With Advanced Non-Small Cell Lung Cancer in the Community Setting

Presley C, Tang D, Soulos P, Chiang A, Longtine J, Adelson K, Herbst R, Zhu W, Nussbaum N, Sorg R, Agarwala V, Abernethy AP, Gross C

August 2018

Manuscript

JAMA

Flatiron-authored

Disparities in the use of programmed death 1 immune checkpoint inhibitors

O’Connor, JM, Seidl-Rathkopf, K, Torres, AZ, You, P, Carson, KR, Ross, JS, Gross, CP

July 2018

Manuscript

The Oncologist

Flatiron-authored

Comparative Effectiveness from a Single-Arm Trial and Real-World Data: Alectinib versus Ceritinib

Davies J, Martinec M, Delmar P, Coudert M, Bordogna W, Golding S, Reynaldo M, Crane G

June 2018

Manuscript

Future Medicine

Development and Validation of a High-Quality Composite Real-World Mortality Endpoint

Curtis MD, Griffith S, Tucker M, Taylor M, Capra W, Carrigan G, Holzman B, Torres AZ, You P, Arnieri B, Abernethy AP

June 2018

Abstract

Academy Health Annual Research Meeting

Flatiron-authored

June 2018

Abstract

ASCO Annual Meeting

Flatiron-authored

June 2018

Abstract

ASCO Annual Meeting

Flatiron-authored

June 2018

Abstract

ASCO Annual Meeting

June 2018

Abstract

ASCO Annual Meeting

Risk Stratification Using Patient-Reported Outcomes (PROs) in Patients (pts) with Advanced Cancer

Patel SB, Haaland B, Ose D, Haydell T, Martineau J, Dunson W, Chalmers AW, Cannon L, Kissell B, Meropol N, Akerley W

June 2018

Abstract

ASCO Annual Meeting

Flatiron-authored

June 2018

Abstract

ASCO Annual Meeting

Flatiron-authored

June 2018

Abstract

ASCO Annual Meeting

Flatiron-authored

June 2018

Abstract

ASCO Annual Meeting

June 2018

Abstract

ASCO Annual Meeting

Sequencing of Ramucirumab (ram) and Immune Checkpoint Inhibitors (ICIs) in Platinum (Pt)-Treated Real-World Patients (pts) with Advanced Non-Small Cell Lung Cancer (aNSCLC)

Clarke JM, Molife C, Miksad RA, Batus M, Winfree KB, Gossai A, Stefaniak VJ, Foster R, Cui Z, Torres AZ, Feuchtbaum D, Tawney MK, Bonomi PD

June 2018

Abstract

ASCO Annual Meeting

Flatiron-authored

Identifying the Prognostic Significance of Genomic Alterations in a Real-World, EHR-Derived Clinico-Genomic Database (CGDB)

Agarwala V, Backenroth D, Singal G, O'Connell C, Li G, Alpha-Cobb G, Kaushik G, Carson K, Miller V, Abernethy AP

June 2018

Abstract

ASCO Annual Meeting

Flatiron-authored

Prevalence of Microsatellite Instability and Association with Pembrolizumab (P) Usage in a Real-World Clinico-Genomic Database

O'Connell C, Backenroth D, Singal G, Agarwala V, Li G, Kaushik G, Alpha-Cobb G, Kao CK, Miller V, Abernethy AP, Carson K

June 2018

Abstract

ASCO Annual Meeting

Flatiron-authored

June 2018

Abstract

ASCO Annual Meeting

Flatiron-authored

May 2018

Abstract

ISPOR Annual Meeting

Flatiron-authored

Speed of Adoption of Immune Checkpoint Inhibitors of Programmed Cell Death 1 Protein and Comparison of Patient Ages in Clinical Practice vs Pivotal Clinical Trials

O’Connor J, Fessele K, Steiner J, Seidl-Rathkopf K, Carson K, Nussbaum N, Yin E, Adelson K, Presley C, Chiang A, Ross J, Abernethy AP, Gross C

May 2018

Manuscript

JAMA Oncology

Flatiron-authored

Identification of Resistance Mechanisms to EGFR Treatment in the Real World Using a Clinicogenomic Database

Singal G, Agarwal A, Kaushik G, O'Connell C, Alpha-Cobb G, Caron T, Bourque D, Guria A, Frank S, Frampton G, Carson K, Abernethy AP, Miller V

April 2018

Abstract

American Association for Cancer Research Annual Meeting

Flatiron-authored

Use of Cancer Immunotherapies in the Real-World in the Setting of Microsatellite Instability

Agarwala V, Gossai A, Singal G, O'Connell C, Li G, Kao K, Bourque D, Feuchtbaum D, Nunnally A, Frampton G, Ali S, Abernethy AP, Kramarz S, Trabucco SE

January 2018

Abstract

ASCO-SITC Clinical Immuno-Oncology Symposium

Flatiron-authored

Characteristics of Real-World Metastatic Non-Small Cell Lung Cancer Patients Treated with Nivolumab and Pembrolizumab During the Year Following Approval

Khozin S, Abernethy AP, Nussbaum N, Zhi J, Curtis MD, Tucker M, Lee S, Light D, Gossai A, Sorg R, Torres AZ, Patel P, Blumenthal G, Pazdur R

January 2018

Manuscript

The Oncologist

Flatiron-authored

October 2017

Abstract

World Conference on Lung Cancer

Utilization and Timing of Foundation Medicine (FMI) Testing in U.S. Advanced Non-Small Cell Lung Cancer (aNSCLC) Patients

Wang L, Page D, Shewade A, Lambert P, Arnieri B, Capra W, Khorshid M, Mughal T, Gay L, Foser S

October 2017

Abstract

World Conference on Lung Cancer

October 2017

Abstract

World Conference on Lung Cancer

October 2017

Abstract

World Conference on Lung Cancer

Real-World Management of Patients with EGFR Mutation-Positive NSCLC in the US

Li Y, Appius A, Pattipaka T, Feyereislova A, Cassidy A, Ganti A

October 2017

Abstract

World Conference on Lung Cancer

October 2017

Abstract

World Conference on Lung Cancer

Immune Checkpoint Inhibitor (ICPI) Efficacy and Resistance Detected by Comprehensive Genomic Profiling (CGP) in Non-Small Cell Lung Cancer (NSCLC)

Ross J, Goldberg M, Albacker L, Gay L, Agarwala V, Elvin J, Vergillo J, Ramkissoon S, Severson E, Daniel S, Ali S, Schrock A, Frampton G, Fabrizio D, Miller V, Singal G, Abernethy AP, Stephens P

September 2017

Abstract

ESMO Annual Congress

Flatiron-authored

Analyzing Biomarkers of Cancer Immunotherapy (CIT) Response Using a Real-World Clinico-Genomic Database

Singal G, Miller P, Agarwala V, Li G, Gossai A, Albacker L, Goldberg M, He J, Frank S, Bourque D, Ivanov V, Fabrizio D, Caron T, Parker A, Guria A, Miller V, Elvin J, Ross J, Abernethy AP, Stephens P

September 2017

Abstract

ESMO Annual Congress

Flatiron-authored

June 2017

Manuscript

PLoS One

Flatiron-authored

Adoption of Immunotherapy into Real World Practice: Insights from the Use of Checkpoint Inhibitors

O’Connor J, Seidl-Rathkopf K, You P, Nussbaum N, Torres AZ, Fessele K, Darius K, Adelson K, Yin E, Presley C, Chiang A, Ross J, Abernethy AP, Gross C

June 2017

Abstract

ASCO Annual Meeting

Flatiron-authored

Racial Disparities in the Use of Programmed Death-1 Checkpoint Inhibitors

O’Connor J, Seidl-Rathkopf K, You P, Nussbaum N, Torres AZ, Fessele K, Darius K, Adelson K, Yin E, Presley C, Chiang A, Ross J, Abernethy AP, Gross C

June 2017

Abstract

ASCO Annual Meeting

Flatiron-authored

Disparities in Next Generation Sequencing in a Population-Based Community Cohort of Patients with Advanced Non-Small Cell Lung Cancer

Presley C, Chiang A, Longtine J, Soulos P, Adelson K, Herbst R, Nussbaum N, Sorg R, Abernethy AP

June 2017

Abstract

ASCO Annual Meeting

Flatiron-authored

Development and Validation of a Real-World Clinico-Genomic Database

Singal G, Miller P, Agarwala V, He J, Gossai A, Frank S, Bourque D, Bowser B, Caron T, Baydur E, Seidl-Rathkopf K, Ivanov I, Parker A, Guria A, Frampton G, Jaskiw A, Feuchtbaum D, Nussbaum N, Abernethy AP, Miller V

June 2017

Abstract

ASCO Annual Meeting

Flatiron-authored

June 2017

Abstract

ASCO Annual Meeting

Characteristics of Advanced NSCLC Patients Receiving Molecular Diagnostic Testing in US Routine Clinical Practice

Wang L, Shewade A, Lambert P, Arnieri B, Capra W, Khroshid M, Mughal T, Gay L, Page D, Foser S

June 2017

Abstract

ASCO Annual Meeting

June 2017

Abstract

ASCO Annual Meeting

Flatiron-authored

May 2017

Abstract

European Lung Cancer Conference

March 2017

Abstract

ASCO Quality Care Symposium

Flatiron-authored

March 2017

Abstract

ASCO Quality Care Symposium

December 2016

Abstract

European Society for Medical Oncology ASIA

October 2016

Abstract

EU ISPOR

Contemporary management of advanced non-small cell lung cancer (aNSCLC) in a large, real-world cohort

Presley, CJ, Harrington, E, Gippetti, J, Agarwala, V, Bowser, B, Adelson, KB, Herbst, RS, Abernethy, AP, Gross, CP

June 2016

Abstract

ASCO Annual Meeting

Flatiron-authored

March 2016

Manuscript

Clinical Lung Cancer

Flatiron-authored